Platelets: A new therapeutic target for neurological diseases
Ageing Research Reviews · 2025-12 · 112 · 102874
DOI: 10.1016/j.arr.2025.102874 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Ageing Research Reviews, 2025-12. Verfasst von Xin-Xin Wei und 1 weiteren Autor:innen. Beteiligte Einrichtung: Hengyang Key Laboratory of Neurodegeneration and Cognitive Impairment, Institute of Neuroscience, Hengyang Medical School, University of South China,…. Hauptthemen laut MEDLINE: Blood Platelets, Nervous System Diseases. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 294 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hunan Province.
Abstract (Originalsprache)
Beyond their classical roles in hemostasis and coagulation, accumulating evidence highlights platelets as multifaceted regulators within the nervous system. Research has revealed that platelet-derived factors promote blood-brain barrier (BBB) maturation and angiogenesis via neurochemical pathways. At the same time, platelet-rich plasma (PRP) facilitates neural regeneration by mitigating the neurotoxicity of amyloid-beta (Aβ) and activating the PI3k/Akt signaling pathway. Platelets also modulate synaptic plasticity through NMDA receptor-dependent mechanisms and regulate the synthesis of neurotransmitters. Pathologically, platelets emerge as key contributors to neurodegeneration. They exacerbate Alzheimer's disease (AD) pathology by releasing Aβ and promoting tau hyperphosphorylation, trigger migraines via P2Y12-mediated platelet-leukocyte aggregates and serotonin dysregulation, and amplify neuroinflammation in multiple sclerosis (MS) through CD40L-dependent BBB disruption. Conversely, inhibiting platelet activation using PAFR antagonists (Ginkgolide B), P2Y12 inhibitors (Clopidogrel), or cyclooxygenase modulators (Aspirin) can alleviate neuroinflammation, reduce pathological protein accumulation, and promote functional recovery. This review summarizes the mechanistic roles of platelets in both nervous system physiology and neuropathology, proposing novel platelet-targeted preventive and therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hengyang Key Laboratory of Neurodegeneration and Cognitive Impairment, Institute of Neuroscience, Hengyang Medical School, University of South China, Hengyang, Hunan421001, PR China.
- Hengyang Key Laboratory of Neurodegeneration and Cognitive Impairment, Institute of Neuroscience, Hengyang Medical School, University of South China, Hengyang, Hunan421001, PR China; The Second Affiliated Hospital, Depa…
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hunan Province
Zitieren
APA
Wei, X. X., & Tang, X. Q. (2025). Platelets: A new therapeutic target for neurological diseases. Ageing Research Reviews, 112, 102874. https://doi.org/10.1016/j.arr.2025.102874
Vancouver
Wei XX, Tang XQ. Platelets: A new therapeutic target for neurological diseases. Ageing Research Reviews. 2025;112:102874. doi:10.1016/j.arr.2025.102874
BibTeX
@article{Wei2025,
author = {Wei, Xin-Xin and Tang, Xiao-Qing},
title = {Platelets: A new therapeutic target for neurological diseases},
journal = {Ageing Research Reviews},
year = {2025},
volume = {112},
pages = {102874},
doi = {10.1016/j.arr.2025.102874}
}
EUVIMED